The rise and SURPRISE of the DOACs. St.Emlyn’s
Been a while since we have had any clotology on here. That is unacceptable. So here we go with another journal club fest on the management of acute VTE. Now …
CAP20
JC: Clots in Pots gets Top Spot. Thromboprophylaxis at St.Emlyn’s
Every so often, a paper comes along that contradicts your gut feeling and/or current practice and makes you really think hard. That happened to me this weekend. You may have …
JC: Clots in Pots gets Top Spot. Thromboprophylaxis at St.Emlyn’s Read More »
Nil nocere: do no harm reversing warfarin!
A familiar scenario: You are on duty and your standby phone goes off just as you have come back from your coffee break. The ambulance cell informs you that they …
VTE masterclass with Dan Horner at #RCEM15
You don’t need me to tell you that VTE is a huge problem. 10 million cases worldwide, a cost to the NHS of £466,000,000 and half a million European deaths …
JC: Do all VTE patients need a CT for cancer?
Virchester has a long history of research in the ambulatory management of venous thromboembolism. Several MDs and PhDs have been completed here looking at both therapeutic and diagnostic strategies in …
Get the NOAC Knowhow: Novel Oral Anticoagulants Part 1
Where would we be without warfarin? The good old rat poison has served us brilliantly for decades, allowing us to anticoagulate patients to treat and prevent venous thromboembolism, prevent stroke …
Get the NOAC Knowhow: Novel Oral Anticoagulants Part 1 Read More »
The new oral anticoagulants – the good news – or is it?
A new study in the BMJ this week suggests benefit from use of the new oral anticoagulants. This is of significance to those of us in UK emergency medicine involved in …
The new oral anticoagulants – the good news – or is it? Read More »
The POP, the Chief, his risk assessment and her thromboprophylaxis
So, we’ve already talked about this. But changing times call for changing posts. And we want to know what you think… A 30 year old comes in 10 days after …
The POP, the Chief, his risk assessment and her thromboprophylaxis Read More »